Lurasidone Market was valued at USD 2.5 Billion in 2022 and is projected to reach USD 3.5 Billion by 2030, growing at a CAGR of 5% from 2024 to 2030.
The global Lurasidone market is currently valued at approximately USD 2.5 billion as of 2025, with a projected compound annual growth rate CAGR of 5.8% from 2025 to 2035. The rising prevalence of mental health disorders, particularly schizophrenia and bipolar depression, is driving demand for Lurasidone based therapies. Increasing awareness and diagnosis rates, coupled with advancements in drug formulation and delivery mechanisms, are key factors fueling market growth.
Additionally, the pharmaceutical industry’s focus on personalized medicine and the introduction of generic Lurasidone formulations in emerging markets contribute to market expansion. Trends such as improved patient compliance through once daily dosing and extended release formulations are also influencing growth.
Get an In-Depth Research Analysis of the Global Lurasidone Market Size And Forecast [2025-2032]
Increasing prevalence of psychiatric disorders globally.
Expanding healthcare access in emerging markets.
Innovations in drug delivery systems improving treatment adherence.
Growing demand for antipsychotics with favorable side effect profiles.
High costs associated with branded Lurasidone therapies.
Potential side effects such as metabolic issues and weight gain.
Strict regulatory approval processes slowing new product launches.
Introduction of generic Lurasidone in key markets post patent expiration.
Increased investment in mental health awareness campaigns.
Rising adoption of telemedicine platforms for psychiatric consultations.
Schizophrenia: The primary application, accounting for over 60% of the market share.
Bipolar Depression: A growing segment due to Lurasidone’s dual efficacy in managing depressive episodes and mood stabilization.
Off label Uses: Emerging interest in applications for anxiety disorders and adjunctive therapy in major depressive disorder MDD.
Hospitals: Major contributors due to in house psychiatric treatment programs.
Clinics and Specialty Centers: Significant demand driven by outpatient mental health services.
Online Pharmacies: Rapidly growing due to convenience and rising e commerce adoption.
North America: Leading the market, with the U.S. contributing over 40% of global revenues.
Europe: Significant growth due to increased mental health funding and generic drug uptake.
Asia Pacific: Fastest growing region, driven by population growth and improved healthcare access.
Sumitomo Pharma Co., Ltd.: The original developer and key producer of Latuda Lurasidone, focusing on expanding its global footprint.
Teva Pharmaceuticals: Leading in generic Lurasidone production post patent expiration.
Mylan N.V.: Actively developing cost effective generic formulations for emerging markets.
Sun Pharmaceutical Industries: Strong presence in the Asia Pacific region with a diverse portfolio including Lurasidone generics.
Dr. Reddy’s Laboratories: Emphasizing affordability and accessibility through high quality generics.
Digital Health Integration: Telehealth platforms aiding remote monitoring and prescription management for mental health conditions.
Extended Release Formulations: Enhancing patient adherence and reducing side effects.
Combination Therapies: Ongoing R&D into combining Lurasidone with adjunctive treatments for better outcomes.
AI Driven Drug Development: Accelerating discovery of novel Lurasidone derivatives with optimized efficacy and safety profiles.
Pricing Pressures: High costs limiting access in low income regions.
Regulatory Hurdles: Stringent FDA and EMA approval processes delaying market entry.
Supply Chain Disruptions: Pandemic related challenges affecting raw material availability and distribution networks.
Encouraging generic drug production to reduce costs and enhance accessibility.
Streamlining regulatory frameworks for faster approvals without compromising safety.
Strengthening supply chain resilience through diversified sourcing and localized production hubs.
The Lurasidone market is poised for steady growth, reaching an estimated USD 4.5 billion by 2035. Key growth drivers will include increased global awareness of mental health, advances in drug delivery technologies, and the rising adoption of telehealth services. Efforts to enhance accessibility through affordable generics and innovative formulations will further propel market expansion.
Which region dominates the Lurasidone market? North America leads the market, with the U.S. being the largest contributor.
What are the key applications of Lurasidone? Schizophrenia and bipolar depression are the primary applications, with growing interest in off label uses.
What challenges does the market face? High pricing, regulatory barriers, and supply chain disruptions are major challenges.
Who are the major players? Sumitomo Pharma, Teva Pharmaceuticals, and Sun Pharmaceutical Industries are leading players.
What is the market’s growth potential? The market is expected to grow at a CAGR of 5.8%, reaching USD 4.5 billion by 2035.
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co.
Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical
LTD.
Zhejiang Hisun Pharmaceutical Co.
Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Lurasidone Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Lurasidone Market
Hospital
Psychological Clinic
Others
Based on Types the Market is categorized into Below types that held the largest Lurasidone market share In 2023.
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
120mg/tablet
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Lurasidone Market Research Analysis
1. Introduction of the Global Lurasidone Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Lurasidone Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Lurasidone Market, By Type
6. Global Lurasidone Market, By Application
7. Global Lurasidone Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Lurasidone Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/